-
Merus N.V. Announces Proposed Public Offering of Common Shares
-
Merus N.V. (MRUS) PT Raised to $40 at Roth Capital
-
Merus N.V. (MRUS) Sees Path to Registration for Zenocutuzumab in 1H22 - Roth Capital
-
Merus N.V. (MRUS) Prices 4.85M Share Common Offering at $24.75/Sh
-
Merus Announces Pricing of Public Offering of Common Shares
-
Merus Announces Pricing of Public Offering of Common Shares
-
Merus N.V. (MRUS) PT Raised to $32 at Roth Capital, Following Collaboration Deal Announcement
-
Merus N.V. (MRUS) Prices 4.75M Share Common Offering at $14.50/Sh
-
Merus Announces Pricing of Public Offering of Common Shares
-
Merus Announces Pricing of Public Offering of Common Shares
-
Roth Capital Starts Merus N.V. (MRUS) at Buy

